More on VERU

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.0 Score)

Upcoming Events

- Earnings (11/26/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Veru, Inc. (NQ:VERU)
Delayed: 2.30 -0.08 (3.36%)
Prev. Close $2.38  
Open$2.37 
52 Wk High$ 
52 Wk Low$ 
Day High$2.41 
Day Low$2.28 
P/E N/A  
EPS$ 
Volume99,814 

Friends, Peers and Foes (?): NVO (more...)

Oct 14, 2026 07:09 AM Oppenheimer on Veru, Inc. (VERU): 'We see considerable stock upside from current levels'
Oct 14, 2026 06:52 AM Oppenheimer Reiterates Outperform Rating on Veru, Inc. (VERU)
Oct 6, 2026 01:59 PM Westlake Securities Starts Veru, Inc. (VERU) at Buy
Aug 17, 2026 04:26 PM Form 4 VERU INC. For: Aug 13 Filed by: BARNETTE K GARY
Aug 10, 2026 08:52 AM Form 10-Q VERU INC. For: Jun 30
Aug 10, 2026 08:13 AM Veru, Inc. (VERU) Tops Q3 EPS by 1c
Aug 10, 2026 07:00 AM Form 8-K VERU INC. For: Aug 10
Aug 10, 2026 06:30 AM Veru posts Q3 loss, reports full enrollment in obesity drug trial
Aug 10, 2026 06:30 AM Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
Aug 4, 2026 08:30 AM Veru receives patent allowance for enobosarm and semaglutide combo
View All Articles

Entities mentioned with VERU

View All Entities